Latest news with #RevenueCycleManagement
Associated Press
5 days ago
- Business
- Associated Press
AI and Advanced Analytics Drive Transformation in Physician Revenue Cycle Management: Black Book's 2025 Vendor Rankings by Practice Size and Specialty
Survey findings underscore significant improvements in medical practice denial management, patient engagement, and operational efficiency driven by advanced technologies. DENVER, CO / ACCESS Newswire / June 27, 2025 / Black Book Research, the independent authority on healthcare technology performance, today announced its 2025 rankings of Revenue Cycle Management (RCM) vendors serving U.S. physician practices. Based on survey responses from 8,018 client users across group practices, MSOs, and solo physicians, Black Book assessed vendor performance from September 2024-June 2025 in these 19 essential RCM categories, segmented by practice size and clinical type: End-to-End RCM Software Platforms Primary Care / Medicine-Based Practices Top Vendor: Veradigm Payerpath Awarded for comprehensive RCM workflow automation, payer connectivity, and EHR interoperability. Specialty & Surgical Practices Top Vendor: ModMed BOOST (Modernizing Medicine) Excels in specialty-specific coding automation, surgical billing workflows, and ophthalmology/dermatology integration. __________ Financial Communications & Patient Satisfaction Tools Primary Care / Medicine-Based Practices Top Vendor: Phreesia Praised for large-scale patient intake, digital consent, upfront cost transparency, and patient satisfaction tools. Specialty & Surgical Practices Top Vendor: Luma Health Rated highly for referral communications, surgical prep education, and procedure-specific billing notifications. __________ Patient Engagement & Financial Communications Top Vendor: InteliChart Recognized for its comprehensive patient engagement solutions including portals, scheduling, intake, notifications, surveys, virtual care, and billing communication, significantly enhancing patient satisfaction and revenue collection. __________ Physician Clearinghouse Solutions Top Vendor: Waystar Clearinghouse Rated #1 for large-practice scalability, payer EDI integration, and advanced denial tracking. __________ Patient Financial Access Solutions Top Vendor: Experian Health Integrates financial clearance, ID verification, and prior auth into EHR systems at scale. __________ Outsourced RCM Services EHR System-Based Practices Top Vendor: Greenway Revenue Services Offers end-to-end outsourced RCM services designed specifically for ambulatory and primary care practices, with deep analytics, comprehensive denial management, and EHR integration. EHR-Agnostic RCM Services Top Vendor: R1 RCM Recognized for EHR-agnostic ambulatory RCM services, providing comprehensive outsourced revenue cycle management solutions across diverse physician practice environments. __________ AI-Driven RCM Solutions Top Vendor: IKS Health Specialty-focused, AI-powered RCM solutions excelling in coding automation, payer rule intelligence, predictive analytics, denial management, and scalable staffing augmentation. __________ Physician Practice Claim Processing and Billing Optimization Top Vendor: RapidClaims Recognized for its AI-driven claim processing efficiency, billing accuracy, rapid reimbursement cycles, and client satisfaction specifically tailored to physician practice needs. __________ Revenue Cycle Workflow Optimization Top Vendor: MedEvolve Awarded for its innovative workflow automation solutions, real-time analytics, productivity enhancement, and operational cost reduction specifically tailored for physician groups and practices. __________ Insurance Discovery Solutions Top Vendor: FinThrive Recognized for its efficiency in identifying missed insurance coverage and optimizing reimbursements. __________ Patient Financing & Medical Loan Top Vendor: CarePayment Awarded for superior patient-friendly financing solutions, zero-interest payment plans, flexible repayment options, enhanced patient satisfaction, and increased collection rates. __________ Patient Identifier Solutions & EMPI Top Vendor: Verato Praised for its advanced patient identification technology ensuring accuracy and compliance across multiple practice locations. __________ Patient Revenue Intelligence and Analytics Top Vendor: Innovaccer Recognized for its AI-powered data activation platform (DAP), patient 360 insights, and advanced analytics, providing actionable intelligence to maximize revenue and support value-based care models. __________ Revenue Integrity & Billing Compliance Software Top Vendor: FinThrive Awarded for robust revenue integrity and compliance software tailored specifically for physician practices, proactively managing coding accuracy, compliance oversight, and reimbursement optimization. __________ Extended Business Office Services Top Vendor: Xtend Healthcare Recognized for scalable extended business office (EBO) solutions tailored for physician organizations and MSOs, Xtend Healthcare delivers high-performance A/R resolution, legacy system support, and end-to-end receivables management that accelerates cash flow and reduces administrative burden. __________ Government Reimbursement Services Top Vendor: AdvantEdge Healthcare Solutions Rated highly for its expertise in Medicaid and Medicare reimbursement processes, AdvantEdge supports compliance-driven billing services, encounter data integrity, and appeals management, helping physician practices and FQHCs navigate complex government payer landscapes. __________ Complex Claims Resolution Solutions Top Vendor: Knowtion Health Specializing in complex, denied, or aged claims, Knowtion Health offers robust resolution pathways for high-dollar or regulatory-sensitive A/R, with predictive analytics, payer intelligence, and denial remediation services specifically designed for physician practices and surgical centers. __________ Charge Capture & Price Transparency Tools Top Vendor: Vitalware (by Health Catalyst) Vitalware is recognized for its comprehensive charge capture and pricing transparency platform, enabling physician groups to ensure compliant, complete charge documentation and provide patients with real-time, accurate estimates aligned with No Surprises Act regulations. __________ Payment Processing & Merchant Services for Providers Top Vendor: InstaMed (a J.P. Morgan company) InstaMed leads in secure, compliant payment processing and digital merchant services tailored for physician practices, offering integrated point-of-service collections, online billing, and automated reconciliation across patient and payer transactions. __________ Key Findings from the 2025 Survey 81% of physician groups are actively replacing at least one RCM technology or service vendor in 2025 due to automation gaps or inadequate support for value-based care contracts. 87% of specialty practices report significant improvements in denial management after switching to a top-ranked clearinghouse or outsourcing vendor. 68% of small/solo physicians say that simplified, low-touch billing technology with live customer support is more important than EHR integration. 'No two physician practices are the same. Our segmented rankings by size and specialty give medical leaders the clarity they need to select the right-fit RCM partner,' said Doug Brown, Founder of Black Book Research. 'As value-based models expand and patient financial engagement becomes critical, vendors that serve solo family doctors must be evaluated differently than those supporting 100-provider surgical networks.' About Black Book Research Black Book™ is the leading source for independent, crowdsourced healthcare IT and services vendor performance data. Over 3.4 million healthcare professionals have contributed to Black Book's impartial scoring of over 1,000 RCM software firms and outsourcing partners. Competitive scorecard intelligence reports may be requested through [email protected] . Gratis Black Book industry research reports are available at for all healthcare IT stakeholders. Contact InformationPress Office 8008637590 SOURCE: Black Book Research press release
Associated Press
23-06-2025
- Business
- Associated Press
From Rural Hospitals to Academic Health Systems: 2025's Best End-to-End RCM Vendors Ranked by Client Satisfaction & Performance, Black Book User Survey
Healthcare Finance Leaders Identify Top Software Solutions Across U.S. Hospital Segments Based on Real-World Results, ROI, and Financial Outcomes DENVER, CO / ACCESS Newswire / June 23, 2025 / Black Book Market Research, the independent healthcare tech & services survey firm, has released its highly anticipated rankings for End-to-End Revenue Cycle Management (RCM) Software Vendors, based on survey responses from 11,550 validated RCM professionals, finance leaders, IT users, and clinical billing stakeholders conducted Q3 2024 - Q2 2025. This year's survey examined performance across four key hospital segments: large hospitals and IDNs, community hospitals, small/rural hospitals, and academic medical centers with clinics and outreach. Each top-performing vendor demonstrated excellence across 18 universal RCM Key Performance Indicators (KPIs) and an additional 6 AI and automation-specific KPIs, including denial prevention, compliance, financial impact, usability, and AI transparency. Large Hospitals and Health Systems / IDNs Top Vendor: Waystar Recognized for: Enterprise Scalability, AI-Driven Denial Management, and Deep EHR Interoperability Waystar topped the category for large health systems, earning industry-leading scores in automation, AI transparency, predictive analytics, and client-reported ROI. Clients highlighted the platform's reliability in reducing denials, accelerating reimbursement, and adapting to large-scale, multi-entity environments. Community Hospitals Top Vendor: The SSI Group Recognized for: Compliance-First Design, Mid-Market Customization, and Clean Claims Precision SSI Group was rated highest among community hospital respondents, noted for its ability to balance affordability with powerful payer rules logic, revenue integrity support, and flexible integrations-especially valued by CFOs at mid-sized and regional systems. Small and Rural Hospitals Top Vendor: TruBridge Recognized for: Affordability, Ease of Use, and Reliable Denial Prevention Tools TruBridge led in satisfaction among small and rural providers, with survey respondents citing intuitive workflows, rapid training curves, strong customer support, and measurable impact on revenue capture-particularly with limited staff and resources. Academic Medical Centers with Clinics and Outreach Top Vendor: Waystar Recognized for: Advanced AI Capabilities, Research Compliance, and Multisite Integration Academic institutions ranked Waystar highest for its ability to support outpatient clinics, research compliance needs, and diverse specialty billing. Its performance in AI governance, audit readiness, and transparency set it apart in complex academic environments. 'As margin pressures and workforce shortages intensify across all hospital types, the need for end-to-end RCM platforms that drive measurable financial performance has become mission-critical,' said Doug Brown, Founder and President of Black Book. 'Waystar, The SSI Group, and TruBridge have not only led their respective segments in 2025 but have consistently earned top rankings in prior years reflecting sustained client satisfaction, loyalty, and the agility to evolve with today's complex RCM demands. These vendors continue to set the standard in both foundational revenue cycle functions and next-generation automation.' Survey Methodology Black Book's rigorous methodology includes crowd-sourced polling over an 11-month period from RCM users in hospitals, clinics, and integrated delivery systems. All vendors were evaluated using a comprehensive framework of 24 KPIs, 18 universal and 6 AI-focused, covering financial outcomes, operational efficiency, ethical practices, and technology performance. Respondents assessed vendors without pre-screening or sponsorship influence, and 200 RCM vendor representatives participated to assist in refining the industry KPI framework. Notably, 93% of respondents stated the RCM-specific KPIs used in the 2025 report were 'critically needed to properly differentiate vendor performance. Access Full Rankings & Licensing Each 40 page 2025 report includes complete performance scoring for the top 20 vendors in each category. Competitive insights, market share forecasts, and implementation satisfaction scores are available for licensing. Contact [email protected] for access and distribution rights. About Black Book Market Research Black Book Market Research LLC is the premier source for crowdsourced, unbiased performance evaluations of healthcare IT and managed services. With a legacy dating back to 2004, Black Book provides industry-standard insights based on validated user feedback, influencing purchasing decisions for hospitals, medical groups, health plans, and government agencies worldwide including health provider finance and revenue cycle management solutions. Contact Information Press Office [email protected] 8008637590 SOURCE: Black Book Research press release
Yahoo
15-05-2025
- Business
- Yahoo
Everyday People Financial Reports Q1 2025 Results with 20% Revenue Growth over Q1 2024 and Strategic Advancements Across Core Business Lines
Edmonton, Alberta--(Newsfile Corp. - May 14, 2025) - Everyday People Financial Corp. (TSXV: EPF) (OTCQB: EPFCF) ("Everyday People" or the "Company"), a technology-driven financial services provider, is pleased to announce its consolidated financial results for the three months ended March 31, 2025, marking another milestone in the Company's growth strategy. "Our Q1 performance reflects the momentum of our diversified business strategy. With strong contributions from our revenue cycle management ("RCM") segment and a shift toward capital-light, recurring revenue models in our Financial Services division, we are positioning the Company for sustained growth and profitability," said Gordon Reykdal, Executive Chairman of Everyday People. Key Financial Highlights for the Three Months Ended March 31, 2025 Revenue increased by 20% to $17.7 million, compared to $14.8 million for the same period in 2024. Cash flow from operations improved by $2.3 million, moving from a negative $0.7 million in Q1 2024 to a positive $1.6 million in Q1 2025. Following the expansion of our RCM client base announced in December 2024, the Company began recognizing revenue from these new contracts in Q2 2025, with a growing financial impact throughout the remainder of the year. The Company anticipates increasing its RCM client base by an additional 40% based on its Q1 RCM revenues of $15.1 million this quarter as compared to $12.2 million for the same period in the prior year. 1Adjusted EBITDAThree months ended Three months endedMarch 31, 2025$000 March 31, 2024$000 Adjusted EBITDA reconciliation Net profit before tax 969 1,467 Adjustments Depreciation and amortization 943 799 Acquisition costs - 72 Share-based compensation 116 153 Finance costs 614 897 Gain on contingent consideration (546) - Gain on debt settlement - (286) Total adjustment to net profit before tax 1,127 1,635 Adjusted EBITDA 2,096 3,102 Less: Finance costs (614) (897) Adjusted EBTDA 1,482 2,205 Looking Forward "Everyday People had an exceptionally strong start to the year and remain focused on advancing its capital-light business model and executing on a disciplined acquisition strategy." said Gordon Reykdal, Executive Chairman of Everyday People. "We have a passionate and experienced team of operators delivering on the Company's vision." About Everyday People Financial Corp. Everyday People Financial Corp. is a technology-driven financial services company with a mission to help individuals and businesses manage money better. First established in 1988, we have a workforce of 550 people operating in the United Kingdom and Canada providing fully fee-for-service solutions across two business pillars operating in Canada and the United Kingdom. Revenue Cycle Management (RCM), which helps organizations recover receivables and streamline billing processes without purchasing consumer debt, and Financial Services, which provides digital tools and credit access programs that support Canadians on their financial journey, all without lending money. Founded on the belief that everyone deserves a second chance to rebuild financial health and wealth, the Company is committed to providing affordable, innovative, and responsible financial solutions that create lasting value for our clients, customers, and shareholders. We are changing the way people manage money by enhancing our client and consumer services with our own affordability assessment programs with specialized financial products and literacy programs. We're helping everyday people rebuild their financial health for generational wealth. We stand for creativity and entrepreneurship. Our combination of companies, products and services has been established to ensure we can fulfill consumers' financial needs and service them in a low-cost and effective manner. Financial Statements & Management's Discussion and Analysis This news release should be read in conjunction with Everyday People's consolidated financial statements and "Management's Discussion and Analysis" report for the three months ended March 31, 2024, which have been posted under the Company's profile on SEDAR+ at Non-IFRS Financial Measures This news release makes reference to certain non-IFRS financial measures, including Adjusted EBITDA, and Adjusted EBTDA. "Adjusted EBITDA" is not a recognized measure under IFRS and does not have a standardized meaning prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. "EBITDA" means earnings before finance and interest costs, provision for income tax and amortization and depreciation expenses. "Adjusted EBITDA" is calculated as adding back the share-based compensation, depreciation and amortization expenses, other expenses (income) and other non-operating expenses (income) management considers not directly related to operational performance of the period presented. "Adjusted EBTDA" is not a recognized measure under IFRS and does not have a standardized meaning prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. "EBTDA" means earnings before finance excluding interest costs, provision for income tax and amortization and depreciation expenses. "Adjusted EBTDA" is calculated as adding back the share-based compensation, depreciation and amortization expenses, other expenses (income) and other non-operating expenses (income), and excludes interest costs in the calculation, management considers not directly related to operational performance of the period presented. Adjusted EBITDA and EBTDA, are used as non-IFRS financial measures to provide investors with a supplemental measure of the Company's operating performance and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. The Company believes that securities analysts, investors, and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. The Company's management also uses non-IFRS financial measures to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess the Company's ability to meet its capital expenditure and working capital requirements. Non-IFRS financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for an analysis of the Company's results under IFRS. There are a number of limitations related to the use of non-IFRS financial measures versus their nearest IFRS equivalents. Investors are encouraged to review the consolidated financial statements as at and for the three months ended March 31, 2025 and March 31, 2024, and disclosures in their entirety and are cautioned not to put undue reliance on any non-IFRS financial measure and view it in conjunction with the most comparable IFRS financial measures. In evaluating these non-IFRS financial measures, please be aware that in the future the Company will continue to have the adjustment similar to those adjusted in the presented period. For more information visit: Contact Gordon ReykdalExecutive Chairmanletsconnect@ 888 825 9808 (Press Option 2 for Investor and Media Relations) Cautionary Note Regarding Forward-Looking Statements This news release includes certain "forward-looking statements" or "forward-looking information" (collectively referred to hereafter as "forward-looking statements") under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to financial performance, results of operations, integration of the acquired businesses, and the business, plans, strategy, and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to, expectations and assumptions concerning the Company and the acquired businesses as well as other risks and uncertainties, including those described in the documents filed by the Company on SEDAR+ at There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit
Yahoo
15-05-2025
- Business
- Yahoo
Everyday People Financial Reports Q1 2025 Results with 20% Revenue Growth over Q1 2024 and Strategic Advancements Across Core Business Lines
Edmonton, Alberta--(Newsfile Corp. - May 14, 2025) - Everyday People Financial Corp. (TSXV: EPF) (OTCQB: EPFCF) ("Everyday People" or the "Company"), a technology-driven financial services provider, is pleased to announce its consolidated financial results for the three months ended March 31, 2025, marking another milestone in the Company's growth strategy. "Our Q1 performance reflects the momentum of our diversified business strategy. With strong contributions from our revenue cycle management ("RCM") segment and a shift toward capital-light, recurring revenue models in our Financial Services division, we are positioning the Company for sustained growth and profitability," said Gordon Reykdal, Executive Chairman of Everyday People. Key Financial Highlights for the Three Months Ended March 31, 2025 Revenue increased by 20% to $17.7 million, compared to $14.8 million for the same period in 2024. Cash flow from operations improved by $2.3 million, moving from a negative $0.7 million in Q1 2024 to a positive $1.6 million in Q1 2025. Following the expansion of our RCM client base announced in December 2024, the Company began recognizing revenue from these new contracts in Q2 2025, with a growing financial impact throughout the remainder of the year. The Company anticipates increasing its RCM client base by an additional 40% based on its Q1 RCM revenues of $15.1 million this quarter as compared to $12.2 million for the same period in the prior year. 1Adjusted EBITDAThree months ended Three months endedMarch 31, 2025$000 March 31, 2024$000 Adjusted EBITDA reconciliation Net profit before tax 969 1,467 Adjustments Depreciation and amortization 943 799 Acquisition costs - 72 Share-based compensation 116 153 Finance costs 614 897 Gain on contingent consideration (546) - Gain on debt settlement - (286) Total adjustment to net profit before tax 1,127 1,635 Adjusted EBITDA 2,096 3,102 Less: Finance costs (614) (897) Adjusted EBTDA 1,482 2,205 Looking Forward "Everyday People had an exceptionally strong start to the year and remain focused on advancing its capital-light business model and executing on a disciplined acquisition strategy." said Gordon Reykdal, Executive Chairman of Everyday People. "We have a passionate and experienced team of operators delivering on the Company's vision." About Everyday People Financial Corp. Everyday People Financial Corp. is a technology-driven financial services company with a mission to help individuals and businesses manage money better. First established in 1988, we have a workforce of 550 people operating in the United Kingdom and Canada providing fully fee-for-service solutions across two business pillars operating in Canada and the United Kingdom. Revenue Cycle Management (RCM), which helps organizations recover receivables and streamline billing processes without purchasing consumer debt, and Financial Services, which provides digital tools and credit access programs that support Canadians on their financial journey, all without lending money. Founded on the belief that everyone deserves a second chance to rebuild financial health and wealth, the Company is committed to providing affordable, innovative, and responsible financial solutions that create lasting value for our clients, customers, and shareholders. We are changing the way people manage money by enhancing our client and consumer services with our own affordability assessment programs with specialized financial products and literacy programs. We're helping everyday people rebuild their financial health for generational wealth. We stand for creativity and entrepreneurship. Our combination of companies, products and services has been established to ensure we can fulfill consumers' financial needs and service them in a low-cost and effective manner. Financial Statements & Management's Discussion and Analysis This news release should be read in conjunction with Everyday People's consolidated financial statements and "Management's Discussion and Analysis" report for the three months ended March 31, 2024, which have been posted under the Company's profile on SEDAR+ at Non-IFRS Financial Measures This news release makes reference to certain non-IFRS financial measures, including Adjusted EBITDA, and Adjusted EBTDA. "Adjusted EBITDA" is not a recognized measure under IFRS and does not have a standardized meaning prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. "EBITDA" means earnings before finance and interest costs, provision for income tax and amortization and depreciation expenses. "Adjusted EBITDA" is calculated as adding back the share-based compensation, depreciation and amortization expenses, other expenses (income) and other non-operating expenses (income) management considers not directly related to operational performance of the period presented. "Adjusted EBTDA" is not a recognized measure under IFRS and does not have a standardized meaning prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. "EBTDA" means earnings before finance excluding interest costs, provision for income tax and amortization and depreciation expenses. "Adjusted EBTDA" is calculated as adding back the share-based compensation, depreciation and amortization expenses, other expenses (income) and other non-operating expenses (income), and excludes interest costs in the calculation, management considers not directly related to operational performance of the period presented. Adjusted EBITDA and EBTDA, are used as non-IFRS financial measures to provide investors with a supplemental measure of the Company's operating performance and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. The Company believes that securities analysts, investors, and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. The Company's management also uses non-IFRS financial measures to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess the Company's ability to meet its capital expenditure and working capital requirements. Non-IFRS financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for an analysis of the Company's results under IFRS. There are a number of limitations related to the use of non-IFRS financial measures versus their nearest IFRS equivalents. Investors are encouraged to review the consolidated financial statements as at and for the three months ended March 31, 2025 and March 31, 2024, and disclosures in their entirety and are cautioned not to put undue reliance on any non-IFRS financial measure and view it in conjunction with the most comparable IFRS financial measures. In evaluating these non-IFRS financial measures, please be aware that in the future the Company will continue to have the adjustment similar to those adjusted in the presented period. For more information visit: Contact Gordon ReykdalExecutive Chairmanletsconnect@ 888 825 9808 (Press Option 2 for Investor and Media Relations) Cautionary Note Regarding Forward-Looking Statements This news release includes certain "forward-looking statements" or "forward-looking information" (collectively referred to hereafter as "forward-looking statements") under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to financial performance, results of operations, integration of the acquired businesses, and the business, plans, strategy, and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to, expectations and assumptions concerning the Company and the acquired businesses as well as other risks and uncertainties, including those described in the documents filed by the Company on SEDAR+ at There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-02-2025
- Business
- Yahoo
Healthcare Revenue Cycle Management Software Market to grow by USD 54.95 Billion from 2025 to 2029, Driven by need to reduce revenue leakage, AI impact
NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The healthcare revenue cycle management (RCM) software market and it is set to grow by USD 54.95 billion from 2025 to 2029. However, the growth momentum will progressing at a CAGR of over 13.7% during the forecast period, according to Technavio. The healthcare revenue cycle management (RCM) software market is fragmented, and the vendors are seeking strong partnerships with automotive, industrial, and commercial companies to compete in the market. 3M Co., ALLSCRIPTS HEALTHCARE SOLUTIONS INC., athenahealth Inc., Change Healthcare Inc., Chetu Inc., Cognizant Technology Solutions Corp., CompuGroup Medical SE and Co. KGaA, Computer Programs and Systems Inc., Epic Systems Corp., Experian Plc, International Business Machines Corp., OSP, Providence Health and Services, Quest Diagnostics Inc., QWay Healthcare Inc., R1 RCM Inc., The SSI Group LLC, Waystar Inc., WellSky Corp., and ZH Healthcare Inc. Are some of the major market participants -. To know about the vendor offerings - Request a sample report Healthcare Revenue Cycle Management (RCM) Software Market 2025-2029: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The healthcare revenue cycle management (rcm) software market report covers the following areas: Healthcare Revenue Cycle Management (RCM) Software Market Size Healthcare Revenue Cycle Management (RCM) Software Market Trends Healthcare Revenue Cycle Management (RCM) Software Market Industry Analysis Porter's Five Forces Analysis Customer Landscape The healthcare revenue cycle management (rcm) software market is fragmented, and the degree of fragmentation will accelerate. The growing need for reducing revenue leakage in healthcare system will offer immense growth opportunities. However, the Interoperability issues associated with healthcare RCM software will hamper the market growth Healthcare Revenue Cycle Management (RCM) Software Market 2025-2029: Drivers & Challenges The Healthcare Revenue Cycle Management (RCM) software market is witnessing significant growth due to the increasing need for efficient billing and payment management applications in clinics and laboratories. Key stakeholders, including healthcare providers and patients, seek real-time insights into workflows for data accuracy. RCM solutions are essential for managing claims, ensuring interoperability, and data integration of electronic data from petabytes to terabytes of unstructured and structured data. Epic Systems and CareCloud Corporation lead the market, offering licensing, implementation, IT support, and maintenance services. Buying behavior is influenced by factors like data verification, validation, and custom interfaces. Emerging countries and healthcare facilities in America are adopting RCM software to digitize their legacy systems using HCIT tools. Artificial intelligence, machine learning, algorithms, and predictive analytics are driving innovation in RCM, enhancing drug discovery and improving patient volumes. The Healthcare Revenue Cycle Management (RCM) software market is experiencing significant growth due to the increasing complexity of the healthcare industry. Challenges include virtual assistance for patient engagement, managing medical images, and ensuring patient access and collections. Denials and patterns require specialized expertise, while Electronic Health Records (EHRs) and healthcare integration demand advanced technology. Health information exchanges and data security are crucial concerns in the healthcare market, with ransomware attacks and data breaches a growing threat. Compliance with regulatory landscapes and financial performance optimization are key areas of focus for healthcare payers and providers. Manufacturing companies and outsourcing services offer product development and optimization, while human resources and contract research/development provide valuable services. Financial outcomes are a top priority, requiring in-house research and facilities to stay competitive in the ecosystem market. To learn more about the global trends impacting the future of market research, download a PDF sample Segment Overview This healthcare revenue cycle management (rcm) software market report extensively covers market segmentation by Deployment End-user Geography 1.1 Cloud-based- The healthcare revenue cycle management (RCM) software market is witnessing significant growth, particularly in the cloud-based deployment segment. This trend is driven by the benefits of quick deployment, improved flexibility and scalability, real-time data visibility, and customization capabilities. Cloud-based RCM solutions enable seamless integration with other healthcare software solutions, such as online booking and payment systems. Flexible payment options, including monthly subscriptions and pay-as-you-go models, make these solutions cost-effective for various-sized healthcare organizations. Small and medium-scale healthcare providers are increasingly adopting cloud-based RCM software due to its scalability and cost savings. Large-scale healthcare enterprises, with their vast data volumes, can optimize costs by storing critical data on-premises and infrequently used data on public cloud servers. Innovations in data security will further boost the adoption of cloud-based RCM solutions among large enterprises during the forecast period. In summary, the cloud-based deployment segment is expected to grow at a faster rate than the on-premises deployment segment due to its numerous advantages. To learn more, request a FREE sample Healthcare Revenue Cycle Management (RCM) Software Market 2025-2029: Key Highlights CAGR of the market during the forecast period 2025-2029 Detailed information on factors that will assist healthcare revenue cycle management (rcm) software market growth during the next five years Estimation of the healthcare revenue cycle management (rcm) software market size and its contribution to the parent market Predictions on upcoming trends and changes in consumer behavior The growth of the healthcare revenue cycle management (rcm) software market across North America, Europe, APAC, South America, and Middle East and Africa Analysis of the market's competitive landscape and detailed information on vendors Comprehensive details of factors that will challenge the growth of healthcare revenue cycle management (rcm) software market vendors Healthcare Revenue Cycle Management (RCM) Software Market Scope Report Coverage Details Base year 2024 Historic period 2017-2021 Forecast period 2025-2029 Growth momentum & CAGR Accelerate at a CAGR of 13.7% Market growth 2025-2029 USD 54953.5 million Market structure Fragmented YoY growth 2022-2023 (%) 11.5 Regional analysis North America, Europe, APAC, South America, and Middle East and Africa Performing market contribution North America at 65% Key countries US, Canada, Germany, UK, France, Japan, India, China, Australia, and Brazil Competitive landscape Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks Key companies profiled 3M Co., ALLSCRIPTS HEALTHCARE SOLUTIONS INC., athenahealth Inc., Change Healthcare Inc., Chetu Inc., Cognizant Technology Solutions Corp., CompuGroup Medical SE and Co. KGaA, Computer Programs and Systems Inc., Epic Systems Corp., Experian Plc, International Business Machines Corp., OSP, Providence Health and Services, Quest Diagnostics Inc., QWay Healthcare Inc., R1 RCM Inc., The SSI Group LLC, Waystar Inc., WellSky Corp., and ZH Healthcare Inc. Market dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About USTechnavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@ View original content to download multimedia: SOURCE Technavio
